EREG is a risk factor for the prognosis of patients with cervical cancer

EREG is a risk factor for the prognosis of patients with cervical cancer

BackgroundCervical cancer continues to threaten women's health worldwide. Identifying critical oncogenic molecules is important to drug development and prognosis prediction for patients with cervical cancer. Recent studies have demonstrated that epiregulin (EREG) is upregulated in various cance...

Full description

Bibliographic Details
Main Authors: Tianye Li, Ruijing Feng, Bingxin Chen, Jianwei Zhou
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-03-01
Series:Frontiers in Medicine
Subjects:
EREG
prognosis prediction
biomarker
proliferation
apoptosis
cervical cancer
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2023.1161835/full

Similar Items

Similar Items